flaggen en

flaggen en flaggen dt flaggen it   flaggen es flaggen fr   flaggen he   flaggen pl   flaggen jp   flaggen ar   flaggen inflaggen gr

flaggen en

flaggen en

 SPAEN Advocacy Award Titel 2018

The “SPAEN Advocacy in Action Award 2018” for best projects in sarcoma patient advocacy

Last year, we announced the “SPAEN Advocacy in Action Award” for the first time and were amazed to receive such high-quality, outstanding and interesting submissions. Reason enough for us to continue to make some noise about the projects and initiatives that are being implemented each day, each month or each year in various countries. We want to again celebrate and honour outstanding practices, projects, initiatives or campaigns and the creators working behind these activities.

We therefore invite you to participate in the “SPAEN Advocacy in Action Award 2018”!

The winning projects/teams will receive

  • 1st: 2.000 €
  • 2nd: 1.500 €
  • 3rd: 1.000 €

A jury of 8 representatives – patient advocates and healthcare professionals – will evaluate the submissions and select the winners.

The deadline for submission is December 1st, 2018!
The Award Ceremony will be held during the 9th SPAEN Annual Conference, February 2019

More information about the Advocacy in Action Award 2018 as well as the application can be found here.


Background on the SPAEN Advocacy in Action Award

We were looking for projects, initiatives, campaigns fulfilling the following eligibility criteria:

Participants: All SPAEN member groups
Type of projects:

  Should be sarcoma specific (Soft Tissue, Bone, GIST, Desmoid, Chordoma)

  • For a single entity or for several diseases
  • Already completed or ongoing projects
    (Please: Not just ideas or planned projects!)
Thematic areas:
  •  Patient information & education
  •  Patient support
  •  Improving the quality of life
  •  Social media and digital communications
  •  Generating “real world evidence” (registries, survey, data mining etc.)
  •  Advocacy & lobbying the healthcare system
  •  Being involved or driving sarcoma research